These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18203702)

  • 1. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up.
    Durand E; Mousseaux E; Coste P; Pillière R; Dubourg O; Trinquart L; Chatellier G; Hagège A; Desnos M; Lafont A
    Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Guerrero I; Dhoble A; Fasulo M; Denktas AE; Sami S; Choi S; Balan P; Arain SA; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):971-977. PubMed ID: 27511120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
    Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
    Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
    Seggewiss H; Faber L; Ziemssen P; Gleichmann U
    Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
    Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
    Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    van Dockum WG; Beek AM; ten Cate FJ; ten Berg JM; Bondarenko O; Götte MJ; Twisk JW; Hofman MB; Visser CA; van Rossum AC
    Circulation; 2005 May; 111(19):2503-8. PubMed ID: 15867172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
    van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC
    Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Gaspar J; Martínez-Ríos MA; Vonderwalde C; Rosas M; Ban-Hayashi E; Eidt-Lidt G; Kuri J
    Catheter Cardiovasc Interv; 1999 May; 47(1):73-9. PubMed ID: 10385166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
    Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
    Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic changes in percutaneous transluminal septal coil embolization for hypertrophic obstructive cardiomyopathy.
    Ramcharitar S; Meliga E; Kirschbaum SW; ten Cate FJ; van Geuns RJ; Serruys PW
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):806-10. PubMed ID: 18838967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes.
    Gross CM; Schulz-Menger J; Krämer J; Siegel I; Pilz B; Waigand J; Friedrich MG; Uhlich F; Dietz R
    J Endovasc Ther; 2004 Dec; 11(6):705-11. PubMed ID: 15615561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catheter treatment of hypertrophic obstructive cardiomyopathy].
    Gleichmann U; Seggewiss H; Faber L; Fassbender D; Schmidt HK; Strick S
    Dtsch Med Wochenschr; 1996 May; 121(21):679-85. PubMed ID: 8646974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy and safety of coil embolization of septal branch in the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu H; Wu Q; Tan HW; Pang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1044-1048. PubMed ID: 29325364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
    Gao YC; Li Y; Han ZH; Zhang XL; Zhao H; Jiang TY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):333-6. PubMed ID: 17711659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures.
    Dörge H; Schmitto JD; Liakopoulos OJ; Walther S; Schöndube FA
    Thorac Cardiovasc Surg; 2004 Dec; 52(6):344-8. PubMed ID: 15573275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
    Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.